Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer immunotherapy meets biomaterials

Nature Biotechnology volume 33, pages 44–45 (2015)Cite this article

Subjects

Engineered biomaterials boost the efficacy of cancer vaccines and adoptive T cell therapies.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Biomaterial scaffolds boost the efficacy of immunotherapies.

Katie Vicari/Nature Publishing Group

References

  1. Kim, J. et al. Nat. Biotechnol. 33, 64–72 (2015).

    Article  CAS  Google Scholar 

  2. Stephan, S.B. et al. Nat. Biotechnol. 33, 97–101 (2015).

    Article  CAS  Google Scholar 

  3. Ali, O.A. et al. Sci. Transl. Med. 1, 8ra19 (2009).

    Article  Google Scholar 

  4. Boissonnas, A. et al. Immunity 32, 266–278 (2010).

    Article  CAS  Google Scholar 

  5. Sharma, M.D. et al. J. Clin. Invest. 117, 2570–2582 (2007).

    Article  CAS  Google Scholar 

  6. Messina, J.L. et al. Sci Rep. 2, 765–770 (2012).

    Article  Google Scholar 

  7. Dieu-Nosjean, M.C. et al. J. Clin. Oncol. 26, 4410–4417 (2008).

    Article  CAS  Google Scholar 

  8. Melero, I. et al. Nat. Rev. Clin. Oncol. 11, 509–524 (2014).

    Article  CAS  Google Scholar 

  9. Jones, D. Nat. Rev. Drug Discov. 8, 685–686 (2009).

    Article  CAS  Google Scholar 

  10. Tran, E. et al. Science 344, 641–645 (2014)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jeffrey S. Weber & James J. Mulé are at the Moffitt Cancer Center, Tampa, Florida, USA.,

    Jeffrey S Weber & James J Mulé

Authors
  1. Jeffrey S Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James J Mulé
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey S Weber.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weber, J., Mulé, J. Cancer immunotherapy meets biomaterials. Nat Biotechnol 33, 44–45 (2015). https://doi.org/10.1038/nbt.3119

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3119

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research